New hair loss cream shows promise in large trial
Disease control
Ongoing
This study tests a topical solution called clascoterone for male pattern baldness. About 700 men with mild to moderate hair loss will apply the drug or a placebo twice daily for 6 months, then responders continue for another 6 months. The goal is to see if it safely increases hai…
Phase: PHASE3 • Sponsor: Cassiopea SpA • Aim: Disease control
Last updated Apr 22, 2026 16:00 UTC